NADH-dependent nanaomycin D reductase

NADH-dependent nanaomycin D reductase is an enzyme primarily characterized in the bacterium Streptomyces rosa var. notoensis, where it plays a pivotal role in the biosynthetic pathway of nanaomycin antibiotics (Tanaka et al., 1975). The enzyme specifically facilitates the conversion of nanaomycin D, a naphthoquinone epoxide, into nanaomycin A through a reductive process that utilizes NADH as a necessary electron donor (Tanaka et al., 1975). This enzymatic transformation is a critical step in generating the bioactive forms of nanaomycins, such as nanaomycin A, which has been identified as a potent and selective inhibitor of human DNA methyltransferase 3B (DNMT3B) (Kuck et al., 2010). While the product of this reaction has potential applications in cancer research due to its epigenetic effects, the reductase enzyme itself is not a target for human therapeutic intervention. It is primarily of interest in the fields of microbiology and natural product chemistry for its role in the structural diversification of quinone-based antimicrobial agents (Sunazuka et al., 2008). As a specialized bacterial biosynthetic enzyme, it does not serve as a site for drug action in humans or common pathogens, and thus it is not considered a therapeutic target in the conventional sense.

Other names

Nanaomycin D reductaseNanaomycin D epoxide reductase

The enzyme catalyzes the NADH-dependent reduction of the epoxide moiety in nanaomycin D to a hydroxyl group, converting it into nanaomycin A.